TA
MACK

Teachers Advisors’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Teachers Advisors’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-31,921
Closed -$202K – 3171
2018
Q1 		$202K Hold
31,921
– – ﹤0.01% 2878
2017
Q4 		$257K Sell
31,921
-19,045
-37% -$178K ﹤0.01% 2866
2017
Q3 		$583K Buy
50,966
+51
+0.1% +$536 ﹤0.01% 2516
2017
Q2 		$497K Sell
50,915
-187,741
-79% -$3.84M ﹤0.01% 2601
2017
Q1 		$5.78M Sell
238,656
-81,539
-25% -$2.04M 0.01% 1228
2016
Q4 		$10.3M Sell
320,195
-30,908
-9% -$1.32M 0.02% 947
2016
Q3 		$17.5M Buy
351,103
+24,906
+8% +$1.03M 0.03% 652
2016
Q2 		$13.8M Buy
326,197
+4,610
+1% +$251K 0.02% 726
2016
Q1 		$21.2M Sell
321,587
-17,128
-5% -$894K 0.04% 514
2015
Q4 		$21.1M Buy
338,715
+119,557
+55% +$8.41M 0.04% 521
2015
Q3 		$14.7M Buy
219,158
+57,021
+35% +$4.65M 0.03% 655
2015
Q2 		$15.8M Buy
162,137
+19,208
+13% +$1.83M 0.03% 674
2015
Q1 		$13.4M Buy
142,929
+125,251
+709% +$10.7M 0.03% 766
2014
Q4 		$1.57M Sell
17,678
-2,482
-12% -$181K ﹤0.01% 1776
2014
Q3 		$1.39M Sell
20,160
-32
-0.2% -$1.71K ﹤0.01% 1820
2014
Q2 		$1.16M Hold
20,192
– – ﹤0.01% 1967
2014
Q1 		$801K Hold
20,192
– – ﹤0.01% 2154
2013
Q4 		$848K Buy
20,192
+1,281
+7% +$37.1K ﹤0.01% 2092
2013
Q3 		$565K Buy
18,911
+3,634
+24% +$127K ﹤0.01% 2244
2013
Q2 		$809K Buy
+15,277
New +$670K ﹤0.01% 1974

Other funds holding MACK

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
WIM
Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Teachers Advisors's MACK Position: Q2 2018 in Review

Teachers Advisors sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q2 2018, closing a stake of 31,921 shares — an estimated $202K sold.

Teachers Advisors first reported a position in MACK in Q2 2013 and held it in 20 quarters. The position peaked at $21.2M in Q1 2016. 76 funds tracked by Wall St. Rank hold MACK as of Q2 2018.

  • Teachers Advisors reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
  • Teachers Advisors sold 31,921 Merrimack Pharmaceuticals, Inc. shares in Q2 2018, an estimated $202K.
  • Teachers Advisors first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2013 and held it in 20 quarters.
  • Teachers Advisors's Merrimack Pharmaceuticals, Inc. position peaked at $21.2M in Q1 2016.
  • 76 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q2 2018.

Based on Teachers Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.